Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

639
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
639
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.8K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

83
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
83
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

113
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
113
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

107
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
107
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

107
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
107

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Impella Support as a Bridge to Durable Left Ventricular Assist Device on Aortic Regurgitation Progression and Long-Term Survival.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Vasoactive Medications and the Microcirculation in Septic Shock: A Scoping Review.

Critical care medicine·2026
Same author

Mitral Annular Calcification: Natural History, Prognosis, and Clinical Outcomes.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

Early outcomes in patients undergoing heart re-transplantation in the era of HCV-viremic donors.

Journal of cardiology·2025
Same author

Repeat Interventions After Transcatheter Aortic Valve Replacement: Clinical Characteristics and Outcomes of Redo Transcatheter Aortic Valve Replacement and Surgical Explants.

Structural heart : the journal of the Heart Team·2025
Same author

Structural Heart Interventions in Patients with Left Ventricular Assist Devices.

Reviews in cardiovascular medicine·2025

Related Experiment Video

Updated: Oct 31, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K

Vasoplegia from Continuous Flow Left Ventricular Assist Devices.

Shyama Sathianathan1, Geetha Bhat2, Robert Dowling2

  • 1School of Medicine, Penn State College of Medicine, 500 University Dr, Hershey, PA, 17033, USA. sys5817@psu.edu.

Current Cardiology Reports
|July 1, 2021
PubMed
Summary

Continuous flow left ventricular assist devices (c-LVAD) may increase vasoplegic syndrome risk after heart transplants. Further research is needed to understand this link and improve patient outcomes.

Keywords:
Continuous flowHeart transplantLeft ventricular assist devicePulsatile flowVasoplegiaVasoplegic syndrome

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.7K

Related Experiment Videos

Last Updated: Oct 31, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.7K

Area of Science:

  • Cardiology
  • Transplantation Surgery
  • Critical Care Medicine

Background:

  • Vasoplegic syndrome (VS) is a significant concern after orthotopic heart transplant (OHT), occurring more frequently than after other cardiopulmonary bypass surgeries.
  • Continuous flow left ventricular assist devices (c-LVADs) are increasingly used as a bridge to therapy in OHT, but their role in VS development is debated.
  • Current literature lacks a standardized definition for VS, hindering accurate recognition and management of vasoplegic shock post-OHT.

Purpose of the Study:

  • To review the contested contribution of c-LVADs to vasoplegic syndrome after OHT.
  • To highlight the need for a standardized definition of vasoplegic syndrome for improved clinical management.
  • To explore the potential impact of pulsatility in mitigating vascular dysfunction associated with c-LVADs.

Main Methods:

  • Literature review of studies investigating c-LVADs and vasoplegic syndrome in OHT patients.
  • Analysis of current understanding regarding the mechanisms of VS in the context of c-LVADs.
  • Discussion of the rising incidence of VS with increased c-LVAD utilization.

Main Results:

  • The contribution of c-LVADs to VS post-OHT remains debated in clinical studies.
  • c-LVADs are associated with endothelial dysfunction and altered adrenal receptor sensitivity, potential contributors to VS.
  • The incidence of VS after OHT is increasing, correlating with the rise in c-LVAD use.

Conclusions:

  • A standardized definition for vasoplegic syndrome is crucial for effective recognition and management after OHT.
  • Further clinical research is necessary to elucidate the precise role of c-LVADs in VS development.
  • Investigating the potential benefits of pulsatility in mitigating vascular dysfunction warrants clinical exploration to reduce VS risk.